Fundraising Fox
Insilico Medicine
Hong Kong, US · Founded 2019 · 291 employees on LinkedIn · 20 known investors
Find your way into Insilico Medicine
Sign up to see every warm intro you have to Insilico Medicine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Insilico Medicine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Insilico Medicine uses artificial intelligence to discover and develop new drugs, operating an AI-driven platform for pharmaceutical research and development. It collaborates with global biopharma companies and academic institutions on drug discovery projects.
Founders & leadership
Insilico Medicine was founded in 2019 by Aleksandrs Zavoronkovs, Alex Zavoronkov, Alex Zhavoronkov, and Alex Aliper.
Board
Investors · 20
How we know: the company's own site · the VCSheet dataset · Not right? Tell us
How we know: OrbiMed's portfolio page · the company's own site · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Qiming Venture Partners's portfolio page · the company's own site · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Warburg Pincus's portfolio page · the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
How we know: the company's own site · Not right? Tell us
.jpeg){kind=logo}
How we know: B Capital Group's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: Bold Capital Partners's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: BOLD Longevity's portfolio page · Not right? Tell us
How we know: F-Prime Capital's portfolio page · Not right? Tell us
How we know: Harmonix Fund's portfolio page · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$49.5M disclosed across 4 rounds · 2016–2019
▶$36.8MraisedSep 2019 · 21 investors · BiotechnologyRule 506(b)
- [none] WNL LimitedDirector
- Nisa LeungDirector
- Lennart LeeDirector
- Alex ZavoronkovDirector
- James MellonDirector
- Offering amount
- $36.8M
- Amount sold
- $36.8M
- First sale
- Sep 2019
- Incorporated
- Other, Cayman Islands, 2019
- Federal exemptions
- 06b
▶$6MraisedJun 2018 · 15 investors · BiotechnologyRule 506(b)
- Alex ZhavoronkovExecutive Officer, Director
- James MellonDirector
- Qingsong ZhuExecutive Officer
- Offering amount
- $6M
- Amount sold
- $6M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$4MraisedJul 2017 · 1 investors · BiotechnologyRule 506(b)
- Aleksandrs ZavoronkovsExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $4M
- Minimum investment
- $4M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.8MraisedJul 2017 · 17 investors · BiotechnologyRule 506(b)
- Aleksandrs ZavoronkovsExecutive Officer, Director
- Offering amount
- $2.8M
- Amount sold
- $2.8M
- Minimum investment
- $25K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Insilico Medicine went on to found or lead other companies.
Related companies · 3
Companies working in the same space as Insilico Medicine.
In the news
Insilico Medicine Included in MSCI Global Small Cap Indexes, Gaining Capital Market Endorsement in Core Strengths | The Manila Timesmanilatimes.net · Aug 2026
Insilico Medicine Launches the Industry's First Drug Discovery and Development (DDD) Benchmark as a Service, to Evaluate Frontier AI and Foundation Models on Real-World Science - BioSpacebiospace.com · Jul 2026Frequently asked questions
- What does Insilico Medicine do?
- Insilico Medicine uses artificial intelligence to discover and develop new drugs, operating an AI-driven platform for pharmaceutical research and development. It collaborates with global biopharma companies and academic institutions on drug discovery projects.
- Who founded Insilico Medicine?
- Insilico Medicine was founded by Aleksandrs Zavoronkovs, Alex Zavoronkov, Alex Zhavoronkov, Alex Aliper in 2019.
- Who are Insilico Medicine's investors?
- Insilico Medicine's investors include Lilly Asia Ventures, OrbiMed, Qiming Venture Partners, Warburg Pincus, Baidu Ventures, Eight Roads Ventures, Lake Bleu Capital, Sinovation Ventures and 12 more.
- How much funding has Insilico Medicine raised?
- Insilico Medicine has disclosed $49.5M raised across 4 rounds.
- Where is Insilico Medicine headquartered?
- Insilico Medicine is headquartered in Hong Kong, US.